Drug Dermatology

Hyftor

Payments companies reported to CMS as associated with Hyftor. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$56Kassociated payments (2023-2025)
409clinicians with associated payments
1company reporting

By year

2023 $20K
2024 $21K
2025 $14K

Payments reported as associated with Hyftor, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Pediatric Dermatology $15K
Neurology With Special Qualifications In Child Neurology $12K
Dermatology $11K
Pediatrics $6,378
Neurology (Psychiatry & Neurology) $2,321
Neurodevelopmental Disabilities (Pediatrics) $1,852

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Hyftor

These are the largest totals companies reported as associated with Hyftor. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Anthony Mancini Chicago, IL Pediatrics $5,084.69
Ajay Gupta Cleveland, OH Neurology With Special Qualifications In Child Neurology $4,934.81
Dawn Eichenfield San Diego, CA Pediatric Dermatology $4,931.77
Joyce Teng Palo Alto, CA Pediatric Dermatology $4,562.00
James Wheless Memphis, TN Neurology With Special Qualifications In Child Neurology $2,040.00
Deepti Gupta Seattle, WA Pediatric Dermatology $1,625.00
Elizabeth Thiele Boston, MA Neurology With Special Qualifications In Child Neurology $1,290.00
Ryan Gill Baltimore, MD Neurodevelopmental Disabilities (Pediatrics) $1,290.00
Debopam Samanta Little Rock, AR Neurology With Special Qualifications In Child Neurology $1,290.00
Lawrence Morton Richmond, VA Neurology With Special Qualifications In Child Neurology $1,290.00

Prescribed Hyftor?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.